Circulating IGF2BP3 Can Help Predict Treatment Response In Ewing Sarcoma
A new blood-based test could help doctors better predict treatment success and disease progression in patients with Ewing Sarcoma. Researchers
Read MoreA new blood-based test could help doctors better predict treatment success and disease progression in patients with Ewing Sarcoma. Researchers
Read MoreA major step forward has been made in immunotherapy, specifically focusing on a cancer treatment strategy called the “CD47-SIRPα axis.”
Read MoreA new position statement from the American Society of Clinical Oncology (ASCO) is aimed at making it easier for children
Read MoreThis article explores another promising treatment strategy for Ewing Sarcoma. Doctors often treat this cancer with drugs that damage the
Read MoreThis research article identifies a major Achilles’ heel in Ewing Sarcoma, an aggressive bone and soft tissue cancer that primarily
Read MoreResearchers recently discovered that a specific viral receptor gene called CXADR is highly active in patients with the worst Ewing
Read MoreA recent study presented at the 2026 ASCO Annual Meeting reveals that an oral drug called abemaciclib (brand name Verzenio)
Read MoreAdolescent and young adult (AYA) patients with sarcoma often fall into a medical “gray area” because they are too old
Read MoreClinical trial day one is now in the books. We started the morning at the infusion center where Matt had
Read MoreResearchers have discovered that a specific protein called UBA1 is found in much higher amounts in Ewing Sarcoma cells compared
Read More